IDA
PJP icon

Intelligence Driven Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Intelligence Driven Advisers’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,400
Closed -$565K – 144
2025
Q4 		$565K Hold
5,400
– – 0.08% 67
2025
Q3 		$499K Hold
5,400
– – 0.07% 70
2025
Q2 		$431K Buy
+5,400
New +$431K 0.07% 69

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $2.41B AUM 38.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Intelligence Driven Advisers's PJP Position: Q1 2026 in Review

Intelligence Driven Advisers sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 5,400 shares — an estimated $565K sold.

Intelligence Driven Advisers first reported a position in PJP in Q2 2025 and held it in 3 quarters. The position peaked at $565K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Intelligence Driven Advisers reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Intelligence Driven Advisers sold 5,400 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $565K.
  • Intelligence Driven Advisers first reported a position in Invesco Pharmaceuticals ETF in Q2 2025 and held it in 3 quarters.
  • Intelligence Driven Advisers's Invesco Pharmaceuticals ETF position peaked at $565K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Intelligence Driven Advisers's 13F filing for Q1 2026, filed 15 May 2026.